ImmunityBio Founder Dr. Patrick Soon-Shiong Recognized as One of “100 Most Influential People in Oncology in 2025”
ImmunityBioImmunityBio(US:IBRX) Businesswire·2025-12-29 22:00

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that OncoDaily has recognized Dr. Patrick Soon-Shiong as being one of "The 100 Most Influential People in Oncology in 2025.†Soon-Shiong is the company's Founder, Executive Chairman and Global Chief Scientific and Medical Officer, and is a global thought leader in advancing the goal of a cancer-free society. On its website announcing the honor, OncoDaily highlighted. ...